trending Market Intelligence /marketintelligence/en/news-insights/trending/klt8rppld6t-wubqsfgpva2 content esgSubNav
In This List

Universal Health Services posts YOY rise in Q4'17 net income

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Universal Health Services posts YOY rise in Q4'17 net income

Universal Health Services Inc. posted a year-over-year increase in net income and revenue for the fourth quarter of 2017.

Adjusted net income attributable to the company was $189.6 million, or $2.00 per share, versus $176.0 million, or $1.80 per share, in the fourth quarter of 2016.

The S&P Capital IQ consensus normalized EPS estimate for the period was $1.83.

Net revenue for the period totaled $2.64 billion, up from $2.48 billion in the same quarter of 2016.

Reported net income attributable to the company was $219.6 million, or $2.31 per share, as compared to $174.2 million, or $1.78 per share, in the fourth quarter of 2016.

The Pennsylvania-based company also saw a favorable net aggregate after-tax impact of $30 million, or 31 cents per share, in the fourth quarter.

Full-year results

Adjusted net income attributable to the company for the full year was $725.5 million, or $7.53 per share, compared with $720.2 million, or $7.32 per share, in 2016.

The S&P Capital IQ consensus normalized EPS estimate for 2017 was $7.37.

Net revenue for the full-year reached $10.41 billion, compared with $9.77 billion in 2016. Net income attributable to the company amounted to $752.3 million, or $7.81 per share, versus $702.4 million, or $7.14 per share, a year ago.

Outlook for 2018

For 2018, Universal Health Services expects net revenue to be between $10.92 billion and $11.06 billion. The company is targeting full-year 2018 adjusted EPS of $9.25 to $9.90.

The S&P Capital IQ consensus normalized EPS estimate for 2018 is $8.37.

CapEx is expected to be between $600 million and $625 million.